Adamczyk-Gruszka, O.; Horecka-Lewitowicz, A.; Gruszka, J.; Wawszczak-Kasza, M.; Strzelecka, A.; Lewitowicz, P.
FGFR-2 and Epithelial–Mesenchymal Transition in Endometrial Cancer. J. Clin. Med. 2022, 11, 5416.
https://doi.org/10.3390/jcm11185416
AMA Style
Adamczyk-Gruszka O, Horecka-Lewitowicz A, Gruszka J, Wawszczak-Kasza M, Strzelecka A, Lewitowicz P.
FGFR-2 and Epithelial–Mesenchymal Transition in Endometrial Cancer. Journal of Clinical Medicine. 2022; 11(18):5416.
https://doi.org/10.3390/jcm11185416
Chicago/Turabian Style
Adamczyk-Gruszka, Olga, Agata Horecka-Lewitowicz, Jakub Gruszka, Monika Wawszczak-Kasza, Agnieszka Strzelecka, and Piotr Lewitowicz.
2022. "FGFR-2 and Epithelial–Mesenchymal Transition in Endometrial Cancer" Journal of Clinical Medicine 11, no. 18: 5416.
https://doi.org/10.3390/jcm11185416
APA Style
Adamczyk-Gruszka, O., Horecka-Lewitowicz, A., Gruszka, J., Wawszczak-Kasza, M., Strzelecka, A., & Lewitowicz, P.
(2022). FGFR-2 and Epithelial–Mesenchymal Transition in Endometrial Cancer. Journal of Clinical Medicine, 11(18), 5416.
https://doi.org/10.3390/jcm11185416